Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

Related Articles by Review for PubMed (Select 3456164)

1.

Deficiency of adenosine deaminase in the wasted mouse.

Abbott CM, Skidmore CJ, Searle AG, Peters J.

Proc Natl Acad Sci U S A. 1986 Feb;83(3):693-5.

2.

Analysis of normal and mutant forms of human adenosine deaminase - a review.

Daddona PE, Kelley WN.

Mol Cell Biochem. 1980 Feb 8;29(2):91-101. Review.

PMID:
6988697
4.

Adenosine deaminase deficiency and severe combined immunodeficiency disease.

Van der Weyden MB, Kelley WN.

Life Sci. 1977 May 15;20(10):1645-50. Review. No abstract available.

PMID:
195170
5.

Immunodeficiency secondary to adenosine deaminase deficiency and purine nucleoside phosphorylation deficiency.

Carson DA, Carrera CJ.

Semin Hematol. 1990 Jul;27(3):260-9. Review. No abstract available.

PMID:
2115692
6.

[Adenosine deaminase activity and immune dysfunction (author's transl)].

Bremer H, Bauer I, Brock J.

Allerg Immunol (Leipz). 1981;27(1):3-13. Review. German.

PMID:
6455054
7.

Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.

Hirschhorn R, Ratech H.

Curr Top Hematol. 1983;4:1-35. Review. No abstract available.

PMID:
6413135
8.

[Molecular pathology of immunological deficiency. Apropos of adenosine deaminase deficiency and nucleoside phosphorylase deficiency].

Souillet G.

Pediatrie. 1975 Oct-Nov;30(7):746-56. Review. French. No abstract available.

PMID:
1105387
9.

Clinical delineation of adenosine deaminase deficiency.

Hirschhorn R.

Ciba Found Symp. 1978;(68):35-54. Review. No abstract available.

PMID:
387358
10.

ADA and PNP deficiencies: how it all began.

Giblett ER.

Ann N Y Acad Sci. 1985;451:1-8. Review. No abstract available.

PMID:
3935025
11.

Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.

Zegers BJ, Stoop JW.

Clin Biochem. 1983 Feb;16(1):43-7. Review.

PMID:
6407780
12.

[Immune deficiencies secondary to enzymopathies].

Pérignon JL, Hamet M.

Ann Pediatr (Paris). 1989 Jun;36(6):381-5. Review. French.

PMID:
2502942
13.

Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.

Hirschhorn R.

Birth Defects Orig Artic Ser. 1983;19(3):73-81. Review. No abstract available.

PMID:
6418227
14.

Severe combined immunodeficiency disease, adenosine deaminase deficiency and gene therapy.

Parkman R, Gelfand EW.

Curr Opin Immunol. 1991 Aug;3(4):547-51. Review.

PMID:
1755981
15.

Adenosine deaminiase: characteristics of the normal and mutant forms of the human enzyme.

Daddona PE, Kelley WN.

Ciba Found Symp. 1978;(68):177-91. Review. No abstract available.

PMID:
387356
16.

Somatic cell gene therapy: the model of adenosine deaminase deficiency.

Van Beusechem VW, Kukler A, Bakx TA, Valerio D.

Bone Marrow Transplant. 1989 Dec;4 Suppl 4:133-6. Review. No abstract available.

PMID:
2697426
17.

Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.

Mitchell BS, Kelley WN.

Ann Intern Med. 1980 Jun;92(6):826-31. Review.

PMID:
6247948
18.

Metabolic defects in severe combined immunodeficiency in man and animals.

Magnuson NS, Perryman LE.

Comp Biochem Physiol B. 1986;83(4):701-10. Review.

PMID:
3519064
19.

Genotype is an important determinant of phenotype in adenosine deaminase deficiency.

Hershfield MS.

Curr Opin Immunol. 2003 Oct;15(5):571-7. Review.

PMID:
14499267
20.

[Primary immunodeficiencies. Clinical features and variant forms].

Fontán Casariego G.

Allergol Immunopathol (Madr). 2001 May-Jun;29(3):101-7. Review. Spanish.

PMID:
11434882
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk